Product Profile

Mupirocin 2% Ointment is a potent topical antibacterial agent effective against a wide range of gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) — making it a first-line treatment for impetigo and other primary and secondary skin infections. As a WHO-GMP certified pharmaceutical manufacturer in Baddi, Saar Biotech produces this ointment using controlled manufacturing processes to ensure consistent potency, purity, and stability across every batch.

Manufacturing Advantage

Why Saar Biotech for Mupirocin 2% Ointment?

Since {{ site.Params.founded }}, Saar Biotech has been a distinguished WHO-GMP certified leader in pharmaceutical manufacturing. We utilize advanced micronization and pH-stabilization protocols to deliver unmatched bioavailability for this Mupirocin 2% Ointment formulation.

DCGI Approved

Comprehensive documentation and CDSCO support for rapid market entry in India.

Fast Turnaround

30-45 days lead time for new batches with state-of-the-art logistics.

Pan-India Supply & Contract Manufacturing

Batch Lead Time 30-45 Days (Domestic)
B2B Services Contract & Third-Party
Compliance DCGI & Schedule M Standards
Medical Intelligence

Clinical Q&A for Mupirocin 2% Ointment

Technical data on bioavailability, pediatric dosing protocols, and therapeutic efficacy for healthcare professionals.

What are the clinical indications for Mupirocin 2% Ointment?

Mupirocin Ointment USP, 2% is an RNA synthetase inhibitor antibacterial indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus and Streptococcus pyogenes. It is active against a wide range of gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA). It is also active against certain gram-negative bacteria.

How does Mupirocin work as an antibacterial agent?

Mupirocin inhibits bacterial protein synthesis by reversibly and specifically binding to bacterial isoleucyl transfer-RNA synthetase. This unique mechanism of action makes it effective against bacteria that have developed resistance to other antibiotics, including MRSA. It is produced by fermentation using the organism Pseudomonas fluorescens.

What is the standard dosing and application protocol?

A small amount of Mupirocin Ointment USP, 2% should be applied with a cotton swab or gauze pad to the affected area 3 times daily for up to 10 days. Patients not showing a clinical response within 3 to 5 days should be re-evaluated. The ointment is for topical use only.

What are the key contraindications and precautions?

This drug is contraindicated in individuals with a history of sensitivity reactions to any of its components. The ointment should not be used in the eyes, nose, mouth, or on large areas of broken skin. Prolonged use may result in overgrowth of non-susceptible organisms.

What are the common side effects?

Mupirocin is generally well-tolerated. Common side effects may include burning, stinging, or itching at the application site. If severe irritation or signs of an allergic reaction occur, patients should discontinue use and consult a healthcare professional.
Manufacturing Support

B2B Manufacturing Guide for Mupirocin 2% Ointment

Detailed insights on MOQs, lead times, and regulatory support for contractmanufacturing partners.

What tube sizes and packaging formats are available?
Saar Biotech manufactures Mupirocin 2% Ointment in 5 gm, 10 gm, and 15 gm laminated tube formats. All tubes are supplied with custom-printed label and mono-carton artwork compliant with DCGI and Schedule M labelling requirements. Packaging options include flap cartons, drip-off brand embossed cartons, and shrink pack options.
What is the Minimum Order Quantity (MOQ)?
Our standard MOQ ranges from 5,000 to 10,000 tubes per SKU, depending on tube size and packaging specification. For new pharma brands entering the dermatology segment, we offer flexible entry-level volumes.
What analytical tests are conducted on every batch?
Every batch undergoes HPLC Assay for Mupirocin confirming 100% label claim accuracy per USP specifications. pH testing and viscosity measurement confirm skin compatibility and consistent texture. Microbial Limit Testing (MLT) confirms the preservative system is effective. A complete Certificate of Analysis (COA) is provided with every consignment.
Does Saar Biotech support brand name registration and DCGI approval?
Yes. Our regulatory team provides end-to-end support for DCGI brand name search and approval for topical products. We assist partners in verifying that their chosen brand name is available and compliant with DCGI nomenclature guidelines.
What is the standard manufacturing turnaround time?
For a new third-party manufacturing order, the standard turnaround is 30–45 working days from the date of artwork finalisation and licensing documentation clearance. Repeat orders are typically fulfilled in 20–25 working days.
Call Us
WhatsApp
Email